UPC_CFI_404/2025

PROSTHETIC HEART VALVE

Prozessuale & UnteranträgeKostenfestsetzungenMunich LDGenericCase Closed

Übersicht Entscheidungen Dokumente Zeitverlauf

Parteien

Kläger

Edwards Lifesciences Corporation(Edwards Lifesciences Group)

Vertreter: Boris Kreye (Bird & Bird); Elas Tzschoppe (Bird & Bird); Bernhard Thum (Thum & Partner); Jonas Weickert (Thum & Partner); Siddharth Kusumakar (Powell Gilbert); Tessa Waldron (Powell Gilbert); Bryce Matthewson (Powell Gilbert)

Beklagte

Meril GmbH(Meril Group)
Meril Life Sciences Pvt Ltd.(Meril Group)
Meril Italy S.r.l.(Meril Group)

Richter

Matthias Zigann
Margot Kokke
Tobias Pichlmaier
Stefan Wilhelm

Patente

EP3669828

CPC-Codes: A61F2220/0075, A61F2/2418, A61F2230/0054, A61F2250/0069, A61F2/2412, A61F2250/0097, A61F2/2433, A61F2250/0036

Sektor: Pharmaceutical & Medical

Ausgang

Nur Kosten

Eingereicht: 6. Mai 2025

Erste Entscheidung: 17. Okt. 2025

Sprache: English

The Munich Local Division issued a costs decision in favour of Edwards Lifesciences against Meril, ruling on the reasonableness and proportionality of claimed costs including travel expenses and multiple representatives, and awarding costs in proceedings of above-average complexity.

Im UPC-Register öffnen